Navigation Links
Biodel Reports Second Quarter Fiscal Year 2011 Financial Results
Date:5/5/2011

Business Review

  • Biodel has selected two new recombinant human insulin-based formulation candidates, BIOD-105 and BIOD-107, for clinical development as ultra-rapid-acting mealtime insulins for the treatment of diabetes.  Following recent discussions with the U.S. Food and Drug Administration, Biodel now plans to accelerate the timelines for clinical testing of these new formulations.
  • Biodel has initiated a Phase 1 trial of BIOD-105 and BIOD-107 in a double-blind, three-period cross-over study in patients with Type 1 diabetes.  This trial will evaluate the pharmacokinetic, pharmacodynamic and injection site tolerability profiles of the two experimental insulins relative to Humalog® when delivered by subcutaneous injection.  
  • In parallel with the Phase 1 clinical trial of BIOD-105 and BIOD-107 described above, investigators at Oregon Health and Sciences University will soon initiate a similar comparative study evaluating the use of these formulations and Humalog® when delivered by insulin pumps.  The results of the two Phase 1 trials will be used to select the best formulation for Phase 2 clinical testing, planned to initiate later this year and Phase 3 clinical testing planned to initiate in 2012.
  • Biodel recently named Dr. Brian Pereira as chairman of the company's board of directors.  Dr. Pereira has been a board member since November 2007 and, as an experienced biotechnology executive, brings invaluable expertise to the company.  Former chairman Dr. Charles Sanders will remain a member of Biodel's board.

  • Conference Call and Webcast Information

    Biodel's senior management will host a conference call on May 5, 2011, beginning at 4:30 pm Eastern Daylight Saving Time, to discuss these results and provide a company update. Live audio of the conference call will be available to investors, members of the news media and the general public by dialing 1-877-303-8028 (United States)
    '/>"/>

    SOURCE Biodel Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Biodel to Report Second Quarter Fiscal Year 2011 Financial Results on May 5, 2011
    2. BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
    3. Biodel Announces Appointment of Dr. Brian J.G. Pereira as Board Chairman; Dr. Charles A. Sanders to Remain on Board
    4. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
    5. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
    6. Biodel Inc. to Present at the Roth 23rd Annual OC Growth Stock Conference on March 16, 2011
    7. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
    8. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
    9. Biodel Reports First Quarter Fiscal Year 2011 Financial Results
    10. Biodel to Report First Quarter Fiscal Year 2011 Financial Results on February 3, 2011
    11. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
    (Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
    (Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
    Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
    ... , , , ... announced the start of a phase II human clinical trial of ... people with diabetes mellitus. The randomized, controlled 12-week trial in patients ... Clinic in Rochester, Minn., and McGill University Health Centre in Montreal, ...
    ... Potential to Treat a Broad Spectrum of Migraine,***UPDATED SATELLITE ... common, debilitating neurological disorder that affects,approximately 30 million people ... Limitations of oral triptans, the class of,prescription drugs widely ... between 45 and 90 minutes, substantial variability in,patient response ...
    Cached Medicine Technology:Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes 2MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS 2
    (Date:4/17/2014)... identified the first genetic variant specifically associated with ... for around 10-15 per cent of all breast ... the breast cancer sub-type, called invasive lobular carcinoma, ... of this particular kind of breast cancer, which ... published today (Thursday) in the journal PloS ...
    (Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
    (Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
    (Date:4/17/2014)... older Americans suffer from depression, often brought on by ... a project that followed the lives of thousands ... that Internet use among the elderly can reduce the ... "That,s a very strong effect," said Shelia Cotten, a ... media who led the project. "And it all has ...
    (Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
    Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
    ... ... up the running shoes and get moving. While many older people tend to slow down in ... say that keeping active all year is the key to good health, particulary for senior citizens. ... (Vocus) March 9, 2010 -- With ...
    ... hospitalist at the University of Rochester Medical Center calls ... potential new drugs, in a commentary in the March ... Medical Association . Alec B. O,Connor, M.D., M.P.H., ... Department of Medicine, says that while the U.S. Food ...
    ... ... ... , ... , , ...
    ... , ... ... ... ...
    ... recommendations from a national workshop have been released to ... growing public health problem estimated to affect nearly 1 ... a diverse group of representatives from federal health agencies ... medical and public health communities appear in the ...
    ... oophorectomy) while performing a hysterectomy is common practice to ... procedure is performed in 55 percent of all US ... year. An article in the March/April issue of t ... ovaries (bilateral oophorectomy) while performing a hysterectomy is common ...
    Cached Medicine News:Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 2Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 3Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 4Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 5Health News:Physician calls for more rigorous standards for drugs up for FDA approval 2Health News:Physician calls for more rigorous standards for drugs up for FDA approval 3Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 2Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 3Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 4Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 5Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 2Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 3Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 4Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 5Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 6Health News:VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D. 7Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 2Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 3Health News:New study questions benefits of elective removal of ovaries during hysterectomy 2
    PDA formatted guide containing outlines and detailed information on the diagnosis and treatment of HIV infection and AIDS....
    PDA version of the best-selling guide....
    PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
    More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003....
    Medicine Products: